Australia LDL Test Market Size & Outlook, 2025-2033


Australia LDL Test Market Insights

  • As per Reed Intelligence insights, the Australia LDL Test Market stood at USD 73.35 Million in 2024 and is anticipated to grow to USD 127.07 Million by 2033.
  • The Australia market is expected to advance at a CAGR of 6.32% from 2026 through 2033.
  • In 2024, LDL-C accounted for the highest share of the By Type market size.
  • During the forecast period, LDL-P is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings


  • Australia accounted for 0.84% of the global LDL Test Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional LDL Test Market size by 2033.
  • China will be the fastest-growing market in Asia Pacific, projected to achieve USD 935.72 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 73.35 Million
Market Size In 2033 USD 127.07 Million
Largest segment LDL-C
Units Revenue in USD Million
CAGR 6.32% (2025-2033)
Segmnetation Covered
By Type
  1. LDL-C
  2. LDL-P
  3. LDL-B
  4. Others
By Component
  1. Devices
  2. Kits and Reagents
  3. Others
By Applications
  1. Atherosclerosis
  2. Obesity
  3. Dyslipidemia
  4. Diabetes
  5. Angina
  6. Stroke Carotid Artery Disease
  7. Peripheral Arterial Disease
  8. Others
By End-User
  1. Hospitals
  2. Clinics
  3. Pharmaceutical and Biotechnological Companies
  4. Diagnostic Centers
  5. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends